Login / Signup

A decline in depression treatment following FDA antidepressant warnings largely explains racial/ethnic disparities in prescription fills.

Nicholas J CarsonAna M ProgovacYe WangBenjamin Lê Cook
Published in: Depression and anxiety (2017)
Antidepressant prescription fills declined most postwarning for White youth, suggesting that risk information may have diffused less rapidly to prescribers or caregivers of minorities. Decreases in depression treatment visits help to explain the declines in antidepressant prescribing and were largest for White youth. An increase in incident fluoxetine fills, the only medication indicated for pediatric depression at the time, suggests that the warning may have shifted prescribing practices.
Keyphrases